JP2011519871A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519871A5
JP2011519871A5 JP2011507765A JP2011507765A JP2011519871A5 JP 2011519871 A5 JP2011519871 A5 JP 2011519871A5 JP 2011507765 A JP2011507765 A JP 2011507765A JP 2011507765 A JP2011507765 A JP 2011507765A JP 2011519871 A5 JP2011519871 A5 JP 2011519871A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
salt
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507765A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519871A (ja
JP4790871B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2009/000611 external-priority patent/WO2009135299A1/en
Publication of JP2011519871A publication Critical patent/JP2011519871A/ja
Publication of JP2011519871A5 publication Critical patent/JP2011519871A5/ja
Application granted granted Critical
Publication of JP4790871B2 publication Critical patent/JP4790871B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507765A 2008-05-05 2009-05-04 レニン阻害剤としての3,4−置換ピペリジン誘導体 Expired - Fee Related JP4790871B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12652908P 2008-05-05 2008-05-05
US61/126,529 2008-05-05
US18830308P 2008-08-07 2008-08-07
US61/188,303 2008-08-07
PCT/CA2009/000611 WO2009135299A1 (en) 2008-05-05 2009-05-04 3, 4 - substituted piperidine derivatives as renin inhibitors

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2011123054A Division JP5587246B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての3,4−置換ピペリジン誘導体
JP2011123057A Division JP5653842B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての3,4−置換ピペリジン誘導体

Publications (3)

Publication Number Publication Date
JP2011519871A JP2011519871A (ja) 2011-07-14
JP2011519871A5 true JP2011519871A5 (cg-RX-API-DMAC10.html) 2011-08-25
JP4790871B2 JP4790871B2 (ja) 2011-10-12

Family

ID=41264366

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011507765A Expired - Fee Related JP4790871B2 (ja) 2008-05-05 2009-05-04 レニン阻害剤としての3,4−置換ピペリジン誘導体
JP2011123054A Expired - Fee Related JP5587246B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての3,4−置換ピペリジン誘導体
JP2011123057A Expired - Fee Related JP5653842B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての3,4−置換ピペリジン誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011123054A Expired - Fee Related JP5587246B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての3,4−置換ピペリジン誘導体
JP2011123057A Expired - Fee Related JP5653842B2 (ja) 2008-05-05 2011-06-01 レニン阻害剤としての3,4−置換ピペリジン誘導体

Country Status (23)

Country Link
US (1) US8889714B2 (cg-RX-API-DMAC10.html)
EP (1) EP2274295B1 (cg-RX-API-DMAC10.html)
JP (3) JP4790871B2 (cg-RX-API-DMAC10.html)
KR (2) KR101403311B1 (cg-RX-API-DMAC10.html)
CN (1) CN102015682B (cg-RX-API-DMAC10.html)
AU (1) AU2009243875B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0912388A2 (cg-RX-API-DMAC10.html)
CA (1) CA2722734C (cg-RX-API-DMAC10.html)
CO (1) CO6311081A2 (cg-RX-API-DMAC10.html)
CR (1) CR11809A (cg-RX-API-DMAC10.html)
DO (1) DOP2010000329A (cg-RX-API-DMAC10.html)
EA (1) EA020853B1 (cg-RX-API-DMAC10.html)
ES (1) ES2548134T3 (cg-RX-API-DMAC10.html)
IL (1) IL208467A (cg-RX-API-DMAC10.html)
MA (1) MA32296B1 (cg-RX-API-DMAC10.html)
MX (1) MX2010012067A (cg-RX-API-DMAC10.html)
MY (1) MY152042A (cg-RX-API-DMAC10.html)
NI (1) NI201000188A (cg-RX-API-DMAC10.html)
NZ (1) NZ589019A (cg-RX-API-DMAC10.html)
PL (1) PL2274295T3 (cg-RX-API-DMAC10.html)
SG (1) SG192543A1 (cg-RX-API-DMAC10.html)
SV (1) SV2010003723A (cg-RX-API-DMAC10.html)
WO (1) WO2009135299A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3034994A1 (en) 2008-06-03 2009-12-10 Intermune, Inc. Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders
US20110237622A1 (en) * 2008-12-10 2011-09-29 Merck Frosst Canada Ltd. Renin inhibitors
TWI562977B (en) * 2010-11-05 2016-12-21 Bayer Ip Gmbh Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation
UA112897C2 (uk) * 2012-05-09 2016-11-10 Байєр Фарма Акцієнгезелльшафт Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CA2943363A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
CN107602381B (zh) * 2017-09-11 2021-03-16 陕西莱特光电材料股份有限公司 一种萘甲酸酯类衍生物及其制备方法
CN108033876A (zh) * 2017-12-20 2018-05-15 江汉大学 一种5-溴-2-氯苯甲醛的制备方法
EP3887357A1 (en) 2018-11-28 2021-10-06 Basf Se Pesticidal compounds
WO2021219513A1 (en) 2020-04-28 2021-11-04 Basf Se Pesticidal compounds

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380758A (en) 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
IL123293A (en) 1995-09-07 2003-06-24 Hoffmann La Roche Piperidine derivatives, their preparation and pharmaceutical compositions containing them
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
JP2001504457A (ja) 1996-11-01 2001-04-03 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化ホスホジエステラーゼ阻害剤化合物、組成物及びその使用法
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1292426B1 (it) * 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
ATE419239T1 (de) 2000-10-20 2009-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung von 4-phenoxy chinolin derivaten
MXPA04010608A (es) 2002-04-29 2004-12-13 Actelion Pharmaceuticals Ltd Derivados de 7-aril-3,9-diazabiciclo(3.3.1)non-6-eno y sus usos como inhibidores de renina en el tratamiento de enfermedades de hipertension, cardiovasculares o renales.
BR0312000A (pt) 2002-06-27 2005-03-22 Actelion Pharmaceuticals Ltd Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos
US20040204455A1 (en) 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
CA2521951A1 (en) 2003-04-28 2004-11-11 Actelion Pharmaceuticals Ltd Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
CN1972912A (zh) 2003-04-29 2007-05-30 埃科特莱茵药品有限公司 新型3,4-二取代的1,2,3,6-四氢吡啶衍生物
WO2004096803A1 (en) 2003-04-30 2004-11-11 Actelion Pharmaceuticals Ltd Azabicyclononene derivatives
US20060258648A1 (en) 2003-04-30 2006-11-16 Olivier Bezencon 9-Azabicyclo'3.3.1 inon-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors
MXPA05011497A (es) 2003-04-30 2005-12-15 Actelion Pharmaceuticals Ltd Derivados de tropano y su uso como inhibidores de la enzima de conversion de angiotensina (ace).
AU2004233577A1 (en) 2003-05-02 2004-11-11 Actelion Pharmaceuticals Ltd. Diazabicyclononene derivatives
TW200513461A (en) 2003-10-01 2005-04-16 Speedel Experimenta Ag Organische verbindungen
US20080234305A1 (en) 2003-10-09 2008-09-25 Olivier Bezencon Novel Tetrahydropyridine Derivatives
AU2004283821A1 (en) 2003-10-13 2005-05-06 Actelion Pharmaceuticals Ltd. Diazabicyclononene derivatives and their use as renin inhibitors
CN1930170A (zh) 2003-10-23 2007-03-14 埃科特莱茵药品有限公司 二氮杂二环壬烯及四氢吡啶衍生物用作肾素抑制剂
WO2005054243A1 (en) 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives and their use as renin inhibitors
AU2004295092A1 (en) 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd. Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
TW200613274A (en) * 2004-07-09 2006-05-01 Speedel Experimenta Ag Organic compounds
WO2006021403A1 (en) 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicyclononene derivatives
WO2006021401A2 (en) 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicylononene derivatives
AU2005276624B2 (en) 2004-08-25 2011-09-29 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives as renin inhibitors
WO2006021399A2 (en) 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Azabicyclononene derivatives as renin inhibitors
WO2006058546A1 (en) 2004-12-01 2006-06-08 Actelion Pharmaceuticals Ltd Novel lactame derivatives as renin inhibitors
TW200634014A (en) 2004-12-08 2006-10-01 Actelion Pharmaceuticals Ltd Novel diazabicyclononene derivative
WO2006063610A1 (en) 2004-12-17 2006-06-22 Actelion Pharmaceuticals Ltd Heteroaryl substituted diazabicyclononene derivatives
GB0428526D0 (en) * 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
EP1846407B1 (en) 2005-01-28 2011-06-29 Actelion Pharmaceuticals Ltd. 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitor of renin for the treatment of hypertension.
WO2006092268A1 (en) 2005-03-02 2006-09-08 Actelion Pharmaceuticals Ltd Bicyclic five-membered heteroaryl derivatives and their use as renin inhibitors
GB0504850D0 (en) 2005-03-09 2005-04-13 Novartis Ag Organic compounds
US20090270380A1 (en) 2005-03-31 2009-10-29 Peter Herold 3,4,5-Substituted Piperidines as Renin Inhibitors
TW200716622A (en) 2005-03-31 2007-05-01 Speedel Experimenta Ag Substituted piperidines
GB0510810D0 (en) * 2005-05-26 2005-06-29 Novartis Ag Organic compounds
CA2608212A1 (en) 2005-05-27 2006-12-07 Actelion Pharmaceuticals Ltd Novel piperidine carboxylic acid amide derivatives
GB0511063D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
WO2006131884A2 (en) 2005-06-07 2006-12-14 Actelion Pharmaceuticals Ltd Thiazole substituted diazabicyclononane or-nonene derivatives as renin inhibitors
WO2007009250A1 (en) 2005-07-22 2007-01-25 Merck Frosst Canada Ltd. Renin inhibitors
WO2007034406A1 (en) 2005-09-22 2007-03-29 Actelion Pharmaceuticals Ltd Pyrrolidine-3-carboxylic acid amide derivatives and their use as inhibitors of renin
WO2007034445A2 (en) 2005-09-26 2007-03-29 Actelion Pharmaceuticals Ltd Novel piperazine derivatives as renin inhibitors for cardiovascular events and renal insufficiency
WO2007049224A1 (en) 2005-10-25 2007-05-03 Actelion Pharmaceuticals Ltd Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives
EP2420491B1 (en) 2005-12-30 2013-07-03 Novartis AG 3 , 5-substitued piperidine compounds as renin inhibitors
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
JP2009526767A (ja) 2006-02-02 2009-07-23 アクテリオン ファーマシューティカルズ リミテッド 新規二級アミン
CA2642424A1 (en) 2006-03-03 2007-09-07 Actelion Pharmaceuticals Ltd. Primary amines as renin inhibitors
JP2009529033A (ja) 2006-03-08 2009-08-13 アクテリオン ファーマシューティカルズ リミテッド 新規アミン
JP2010503682A (ja) 2006-09-18 2010-02-04 ビテ ファーマシューティカルズ, インコーポレイテッド レニン阻害剤としてのピペリジン誘導体
JP2010510176A (ja) * 2006-11-17 2010-04-02 メルク フロスト カナダ リミテツド レニン阻害剤
WO2008141462A1 (en) * 2007-05-24 2008-11-27 Merck Frosst Canada Ltd. Novel case of renin inhibitors
CA2695461A1 (en) 2007-08-07 2009-02-12 Merck Frosst Canada Ltd. Renin inhibitors
AU2008331456A1 (en) * 2007-12-04 2009-06-11 Merck Frosst Canada Ltd Renin inhibitors
JP2011520924A (ja) 2008-05-22 2011-07-21 メルク フロスト カナダ リミテツド レニン阻害剤としての3,4−置換ピペリジン誘導体
WO2011020193A1 (en) 2009-08-18 2011-02-24 Merck Frosst Canada Ltd. Renin inhibitors

Similar Documents

Publication Publication Date Title
JP2012111758A5 (cg-RX-API-DMAC10.html)
JP2012107057A5 (cg-RX-API-DMAC10.html)
JP2011519871A5 (cg-RX-API-DMAC10.html)
JP2007269812A5 (cg-RX-API-DMAC10.html)
JP2009149903A5 (cg-RX-API-DMAC10.html)
JP2011102971A5 (cg-RX-API-DMAC10.html)
JP2009502793A5 (cg-RX-API-DMAC10.html)
JP2013532130A5 (cg-RX-API-DMAC10.html)
JP2010019854A5 (cg-RX-API-DMAC10.html)
JP2011105738A5 (cg-RX-API-DMAC10.html)
JP2009091350A5 (cg-RX-API-DMAC10.html)
JP2009091351A5 (cg-RX-API-DMAC10.html)
JP2012255926A5 (cg-RX-API-DMAC10.html)
JP2011510079A5 (cg-RX-API-DMAC10.html)
JP2013541578A5 (cg-RX-API-DMAC10.html)
JP2011518833A5 (cg-RX-API-DMAC10.html)
JP2013532687A5 (cg-RX-API-DMAC10.html)
JP2009545527A5 (cg-RX-API-DMAC10.html)
JP2012031285A5 (cg-RX-API-DMAC10.html)
JP2010049241A5 (cg-RX-API-DMAC10.html)
JP2010070692A5 (cg-RX-API-DMAC10.html)
JP2011052077A5 (cg-RX-API-DMAC10.html)
JP2010037339A5 (cg-RX-API-DMAC10.html)
JP2010233885A5 (cg-RX-API-DMAC10.html)
JP2012098270A5 (cg-RX-API-DMAC10.html)